Compare BABA & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BABA | TMO |
|---|---|---|
| Founded | 1999 | 1956 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.4B | 223.0B |
| IPO Year | 2014 | 1996 |
| Metric | BABA | TMO |
|---|---|---|
| Price | $128.26 | $587.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 18 |
| Target Price | $185.15 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 7.8M | 2.1M |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.81% | 0.40% |
| EPS Growth | N/A | ★ 7.32 |
| EPS | N/A | ★ 9.10 |
| Revenue | N/A | ★ $20,918,000,000.00 |
| Revenue This Year | $5.05 | $6.55 |
| Revenue Next Year | $10.83 | $5.11 |
| P/E Ratio | ★ $21.20 | $64.34 |
| Revenue Growth | N/A | ★ 14.47 |
| 52 Week Low | $91.99 | $435.27 |
| 52 Week High | $192.67 | $643.99 |
| Indicator | BABA | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 61.44 | 60.90 |
| Support Level | $119.55 | $557.05 |
| Resistance Level | $133.21 | $596.47 |
| Average True Range (ATR) | 2.70 | 12.55 |
| MACD | -0.16 | -2.27 |
| Stochastic Oscillator | 81.11 | 54.13 |
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China retail e-commerce platform is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China wholesale e-commerce, international retail and wholesale e-commerce, local consumer services, travel services, cloud computing, digital media and entertainment, Cainiao logistics services, and other businesses.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).